Austedo XR 30 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FEJBU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $144,620
Award facts
- Contract value 100% obligated
- $144,619.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $144,619.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for AUSTEDO XR 30 mg tablets on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AUSTEDO XR is a prescription medication used in the treatment of tardive dyskinesia, a movement disorder. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements through open competition, ranging from small transactions to orders exceeding $45,000. This delivery order fulfills ongoing medical supply needs through the DLA's established pharmaceutical prime vendor framework supporting the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEJBU?
SPE2DB25FEJBU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FEJBU worth?
The government has obligated $144,620 on SPE2DB25FEJBU.
Is contract SPE2DB25FEJBU an order under another contract?
Yes. SPE2DB25FEJBU is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEJBU competed?
The extent of competition for SPE2DB25FEJBU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award